Cryopreservation solution for cultured NKT cells and preparation method of cryopreservation solution
A technology of NKT cells and cryopreservation solution, applied in the field of cell cryopreservation solution, can solve problems such as adverse reactions, pollution and allergens, and affect treatment results, and achieve high safety, maintain activity, and good cryopreservation effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030] This embodiment provides a method for preparing a frozen storage solution of cultured NKT cells, comprising the following steps:
[0031] 1) Add lentinan with a concentration of 1-6 mg / mL and seaweed polysaccharide with a concentration of 0.05-0.2 mg / mL into autologous serum respectively, then slowly add DMSO, and add lentinan: seaweed polysaccharide: autologous serum: DMSO according to the volume ratio 1~3:1~3:1~5:1, put the prepared solution A in the refrigerator at 2~8℃ to pre-cool, and set aside;
[0032] 2) Then take out the above solution A, slowly add it to the autologous serum, add solution A: autologous serum ratio of 1-3:1 by volume percentage, and prepare NKT cell cryopreservation solution.
Embodiment 2
[0034] In this example, the cryopreservation solution of cultured NKT cells was prepared according to the method described in Example 1. The cryopreservation solution was prepared from solution A and autologous serum, and the volume ratio of solution A and autologous serum was 1:1. in:
[0035] The solution A includes lentinan, seaweed polysaccharide, autologous serum and DMSO, wherein the volume ratio of lentinan, seaweed polysaccharide, autologous serum and DMSO is 1:1:1:1, wherein the concentration of lentinan is 1 mg / mL, and the seaweed The polysaccharide concentration was 0.05 mg / mL.
Embodiment 3
[0037] In this example, a cryopreservation solution of cultured NKT cells was prepared according to the method described in Example 1. The cryopreservation solution was prepared from solution A and autologous serum, and the volume ratio of solution A and autologous serum was 2:1. in:
[0038] The solution A includes lentinan, seaweed polysaccharide, autologous serum and DMSO, wherein the volume ratio of lentinan, seaweed polysaccharide, autologous serum and DMSO is 2:2:3:1, wherein the concentration of lentinan is 6 mg / mL, and the seaweed The polysaccharide concentration was 0.2 mg / mL.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com